Amprion Launches SAAmplify®-?SYN Plus: The First & Only Commercially Available CSF Test to Detect Alpha-Synuclein Profile for Multiple System Atrophy

SAN DIEGO–(BUSINESS WIRE)–Amprion Launches SAAmplify®-?SYN Plus: The First & Only Commercially Available CSF Test to Detect Alpha-Synuclein Profile for Multiple System Atrophy
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks